Evidence map›Paper›PMID 27023865›Full record

ArticleBasic research in cardiology2016

Electrophysiology and metabolism of caveolin-3-overexpressing mice.

Jan M Schilling, Yousuke T Horikawa, Alice E Zemljic-Harpf, Kevin P Vincent, Leonid Tyan, Judith K Yu, Andrew D McCulloch, Ravi C Balijepalli, Hemal H Patel, David M Roth

Open access · greenAbstract read
In one paragraph

Article in Basic research in cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Species-Dependent Mechanisms of Cardiac Arrhythmia: A Cellular Focus.Clinical Medicine Insights. Cardiology · 2017
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jan M SchillingVeterans Affairs San Diego Healthcare System, San Diego, CA, USA.
Yousuke T HorikawaDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Alice E Zemljic-HarpfVeterans Affairs San Diego Healthcare System, San Diego, CA, USA.
Kevin P VincentDepartment of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Leonid TyanDepartment of Medicine, Cellular and Molecular Arrhythmia Research Program, University of Wisconsin, Madison, WI, USA.
Judith K YuDepartment of Anesthesiology, University of California San Diego, La Jolla, CA, USA.
Andrew D McCullochDepartment of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Ravi C BalijepalliDepartment of Medicine, Cellular and Molecular Arrhythmia Research Program, University of Wisconsin, Madison, WI, USA.
Hemal H PatelVeterans Affairs San Diego Healthcare System, San Diego, CA, USA.
David M RothVeterans Affairs San Diego Healthcare System, San Diego, CA, USA. droth@ucsd.edu.
University of California, San Diego · USUniversity of Wisconsin–Madison · USVA San Diego Healthcare System · USLa Jolla Bioengineering Institute · US

Funding

Vector Production CoreP01HL066941 · NHLBI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI MIYANOHARA, ATSUSHI · 2001 to 2017
$34.8M
National Biomedical Computation Resource - Competitive Revision SupplementP41GM103426 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E · 2012 to 2019
$14.0M
Caveolae, mitochondria, and cardiac protection.R01HL091071 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PATEL, HEMAL H · 2008 to 2019
$3.8M
Integrative Bioengineering of Heart, Vessels, and BloodT32HL105373 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHIEN, SHU, INTAGLIETTA, MARCOS · 2010 to 2019
$3.6M
Multi-scale Systems Model of Murine Heart FailureR01HL105242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BERS, DONALD M, MCCULLOCH, ANDREW D. · 2012 to 2016
$3.5M
Caveolae and L-type Calcium Channels in CardiomyocytesR01HL078878 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BALIJEPALLI, RAVI CHANDRA, KAMP, TIMOTHY J. · 2007 to 2016
$3.1M
Integrins and Caveolin Proteins in Cardiac Hypertrophy and FailureR01HL115933 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSS, ROBERT SCOTT, ROTH, DAVID M · 2013 to 2016
$2.6M
Protection of the Aged MyocardiumR01HL107200 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PATEL, HEMAL H, ROTH, DAVID M · 2011 to 2014
$2.1M
Caveolae, T-type Calcium Channels and Cardiac HypertrophyR01HL105713 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI KAMP, TIMOTHY J. · 2012 to 2016
$1.9M
Modeling Cytosolic and Nuclear Ca2+ and IP3 Signaling in Ventricular MyocytesR03EB014593 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCCULLOCH, ANDREW D. · 2013 to 2014
$153k
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.I01BX000783 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI ROTH, DAVID M · 2011 to 2019
–
Novel Therapeutics for Diabetic CardiomyopathyI01BX001963 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI PATEL, HEMAL H · 2013 to 2025
–
BLRD VA I01 BX000783BLRD VA I01 BX001963NHLBI NIH HHS HL066941NHLBI NIH HHS HL078878NHLBI NIH HHS HL091071NHLBI NIH HHS HL105242NHLBI NIH HHS HL105713NHLBI NIH HHS HL107200NHLBI NIH HHS HL115933NHLBI NIH HHS P01 HL066941NHLBI NIH HHS R01 HL078878NHLBI NIH HHS R01 HL091071NHLBI NIH HHS R01 HL105242NHLBI NIH HHS R01 HL105713NHLBI NIH HHS R01 HL107200NHLBI NIH HHS R01 HL115933NHLBI NIH HHS T32 HL105373NIBIB NIH HHS EB014593NIBIB NIH HHS R03 EB014593NIGMS NIH HHS GM103426NIGMS NIH HHS P41 GM103426
6 · The paper itself

Abstract

Caveolin-3 (Cav-3) plays a critical role in organizing signaling molecules and ion channels involved in cardiac conduction and metabolism. Mutations in Cav-3 are implicated in cardiac conduction abnormalities and myopathies. Additionally, cardiac-specific overexpression of Cav-3 (Cav-3 OE) is protective against ischemic and hypertensive injury, suggesting a potential role for Cav-3 in basal cardiac electrophysiology and metabolism involved in stress adaptation. We hypothesized that overexpression of Cav-3 may alter baseline cardiac conduction and metabolism. We examined: (1) ECG telemetry recordings at baseline and during pharmacological interventions, (2) ion channels involved in cardiac conduction with immunoblotting and computational modeling, and (3) baseline metabolism in Cav-3 OE and transgene-negative littermate control mice. Cav-3 OE mice had decreased heart rates, prolonged PR intervals, and shortened QTc intervals with no difference in activity compared to control mice. Dobutamine or propranolol did not cause significant changes between experimental groups in maximal (dobutamine) or minimal (propranolol) heart rate. Cav-3 OE mice had an overall lower chronotropic response to atropine. The expression of Kv1.4 and Kv4.3 channels, Nav1.5 channels, and connexin 43 were increased in Cav-3 OE mice. A computational model integrating the immunoblotting results indicated shortened action potential duration in Cav-3 OE mice linking the change in channel expression to the observed electrophysiology phenotype. Metabolic profiling showed no gross differences in VO2, VCO2, respiratory exchange ratio, heat generation, and feeding or drinking. In conclusion, Cav-3 OE mice have changes in ECG intervals, heart rates, and cardiac ion channel expression. These findings give novel mechanistic insights into previously reported Cav-3 dependent cardioprotection.

Indexed as

AnimalsCaveolin 3Computer SimulationElectrocardiographyHeartHeart RateImmunoblottingMiceMice, Inbred C57BLMice, TransgenicMyocardiumMyocytes, CardiacCaveolin 3Cardiac conductionCaveolaeCaveolin-3Heart rateKv channels

Identifiers

PMID27023865
PMCPMC5336321
OpenAlexW2324146508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.